FDA Clears Abbott’s AI-Powered Coronary Imaging Software
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.
Abbott has received FDA clearance for a new cardiac mapping platform that is designed to help physicians better treat abnormal heart rhythm.
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.